- Report
- October 2023
- 89 Pages
Malaysia
From €3204EUR$3,500USD£2,723GBP
- Report
- October 2023
- 78 Pages
United States
From €3204EUR$3,500USD£2,723GBP
- Report
- October 2023
- 88 Pages
Malaysia
From €3204EUR$3,500USD£2,723GBP
- Report
- October 2023
- 70 Pages
Canada
From €3204EUR$3,500USD£2,723GBP
- Report
- October 2023
- 83 Pages
Israel
From €3204EUR$3,500USD£2,723GBP
- Report
- October 2023
- 177 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- August 2023
- 75 Pages
Canada
From €3204EUR$3,500USD£2,723GBP
- Report
- August 2023
- 74 Pages
United States
From €3204EUR$3,500USD£2,723GBP
- Report
- August 2023
- 112 Pages
Global
From €4119EUR$4,500USD£3,501GBP
- Report
- July 2023
- 77 Pages
Egypt
From €3204EUR$3,500USD£2,723GBP
- Report
- July 2023
- 78 Pages
Turkey
From €3204EUR$3,500USD£2,723GBP
- Report
- February 2024
- 120 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Report
- February 2024
- 110 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Report
- February 2024
- 71 Pages
Europe
From €4348EUR$4,750USD£3,695GBP
- Report
- February 2024
- 120 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Report
- April 2023
- 71 Pages
Italy
From €4348EUR$4,750USD£3,695GBP
- Report
- April 2023
- 85 Pages
United States
From €4348EUR$4,750USD£3,695GBP
- Report
- April 2023
- 120 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Report
- April 2023
- 120 Pages
Global
From €4348EUR$4,750USD£3,695GBP
- Report
- April 2023
- 69 Pages
United Kingdom
From €4348EUR$4,750USD£3,695GBP

Macular Degeneration is a condition that affects the central part of the retina, known as the macula, which is responsible for sharp, central vision. It is the leading cause of vision loss in people over the age of 50. Optical treatments for Macular Degeneration include laser photocoagulation, photodynamic therapy, and anti-VEGF injections. Laser photocoagulation is used to reduce the risk of further vision loss by sealing off leaking blood vessels in the macula. Photodynamic therapy is used to reduce the growth of abnormal blood vessels in the macula. Anti-VEGF injections are used to reduce the growth of abnormal blood vessels and improve vision.
Companies in the Macular Degeneration market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more